Showing results (151-160 of 296) with videos related to

Sort By:
Pageof 30
European Heart Journal|December 15, 2015
Prognostic value of PCSK9 levels in patients with acute coronary syndromesBaris Gencer, Fabrizio Montecucco, David Nanchen, et al.
Atherosclerosis Plus|October 1, 2024
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesCédric Follonier, Gabriel Rabassa, Mattia Branca, et al.
Journal of Cardiovascular Translational Research|February 26, 2020
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER TrialGiuseppe Gargiulo, Giovanni Esposito, Plinio Cirillo, et al.
Circulation. Cardiovascular Interventions|February 7, 2015
Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantationCrochan J O'Sullivan, Stefan Stortecky, Anne Bütikofer, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarctionChristoph Gräni, Anselm W Stark, Kady Fischer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 10, 2017
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysisStephane Noble, Stefan Stortecky, Dik Heg, et al.
Heart Rhythm O2|August 9, 2024
Comparison of Cryoballoon vs. Pulsed Field Ablation in Patients with Symptomatic Paroxysmal Atrial Fibrillation (SINGLE SHOT CHAMPION): Study protocol for a randomized controlled trialJens Maurhofer, Thomas Kueffer, Sven Knecht, et al.
Circulation|August 16, 2020
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER TrialGiuseppe Gargiulo, Giovanni Esposito, Marisa Avvedimento, et al.
Lancet (London, England)|September 2, 2018
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trialThomas Pilgrim, Raffaele Piccolo, Dik Heg, et al.
JACC. Cardiovascular Interventions|August 19, 2019
Everolimus-Eluting Biodegradable Polymer Versus Everolimus-Eluting Durable Polymer Stent for Coronary Revascularization in Routine Clinical PracticeChristian Zanchin, Yasushi Ueki, Thomas Zanchin, et al.
Pageof 30